ACEA Biosciences Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 201
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $250M
Latest Deal Amount

ACEA Biosciences General Information

Description

Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. The company's instruments use microelectrodes in automated high-throughput plate formats to offer real time cell analysis, enabling doctors to monitor cell proliferation, cell size, cell-substrate attachment quality and cell invasion easily.

Contact Information

Website
www.aceabio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 6779 Mesa Ridge Road
  • Suite 100
  • San Diego, CA 92121
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ACEA Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 14-Nov-2018 $250M 000.00 00000 Completed Generating Revenue
6. Later Stage VC (Series E) 01-Apr-2016 0000 000.00 00000 Completed Generating Revenue
5. Grant 03-Jul-2013 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 10-Sep-2007 00.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 00.000 00.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) $1.85M $4.15M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) $2.3M $2.3M 00.000 Completed Generating Revenue
To view ACEA Biosciences’s complete valuation and funding history, request access »

ACEA Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 0,000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series D 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series C 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series B 1,589,690 $0.001000 4% $1.16 $1.16 1x $1.16 7.98%
Series A 3,199,414 $0.001000 4% $0.95 $0.95 1x $0.95 16.06%
To view ACEA Biosciences’s complete cap table history, request access »

ACEA Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. The company's
Other Devices and Supplies
San Diego, CA
201 As of 2016
000.00
0000 0000-00-00
000000&0 000.00

000000 0

abore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nis
0000000000000
Carlsbad, CA
00 As of 0000
000000000000

00000

do consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
00000 0000000 000 00000000
Fremont, CA
000 As of 0000
00000
0.000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACEA Biosciences Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Active Motif Corporate Backed or Acquired Carlsbad, CA 00 000000000000
00000 Formerly VC-backed Fremont, CA 000 00000 00000000 00000
000000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 0000000000 0 000.00
00000 0000000 0000 Formerly VC-backed San Diego, CA 00 000.00 00000000000 000.00
0000000000 Venture Capital-Backed South San Francisco, CA 00 000.00 0000000000 0 000.00
You’re viewing 5 of 25 competitors. Get the full list »

ACEA Biosciences Patents

ACEA Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3662281-A4 Cell-substrate impedance monitoring of cancer cells of different lineage, origin, or stage Pending 01-Aug-2017 00000000000 0
EP-3662281-A1 Cell-substrate impedance monitoring of cancer cells of different lineage, origin, or stage Pending 01-Aug-2017 00000000000
US-20210364494-A1 Cell-substrate impedance monitoring of cancer cells of different lineage, origin, or stage Pending 01-Aug-2017 00000000000
US-20200071672-A1 Methods and systems for functional maturation of ipsc and esc derived cardiomyocytes Pending 03-Mar-2017 000000000
EP-3589299-A1 Methods and systems for functional maturation of ipsc and esc derived cardiomyocytes Pending 03-Mar-2017 C12N5/0657
To view ACEA Biosciences’s complete patent history, request access »

ACEA Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ACEA Biosciences Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Lilly Asia Ventures Venture Capital Minority 000 0000 000000 0
Qiming Venture Partners Venture Capital Minority 000 0000 000000 0
U.S. Environmental Protection Agency Government 000 0000 000000 0
To view ACEA Biosciences’s complete investors history, request access »